Archives
Stiripentol: LDH, Lactate, and Assay Design
2026-09-09
Stiripentol is a chemically distinct LDH inhibitor for studying lactate flux, neuronal excitability, and Dravet syndrome treatment research. This article connects astrocyte-neuron lactate shuttle modulation with histone lactylation findings and translates them into practical assay decisions.
Phenytoin for Dynamic Myelin Damage Assays
2026-09-09
Phenytoin provides a controllable sodium-channel activity perturbation for linking neuronal firing to early, potentially reversible myelin swelling. This workflow pairs concentration-controlled dosing with live imaging and electrophysiology rather than relying only on endpoint demyelination measurements.
Rottlerin: From PKCδ Mechanism to Translation
2026-09-08
Rottlerin is more than a PKC inhibitor for endpoint-driven assays: it can help translational researchers connect PKCδ signaling with proliferation, apoptosis, endothelial barrier biology, and host–pathogen entry. This thought-leadership perspective outlines how to use Rottlerin rigorously, interpret its selectivity, and extend findings across disease models without overstating preclinical evidence.
Vacuolin-1 Workflows for Lysosomal Exocytosis
2026-09-08
Vacuolin-1 provides a selective way to dissect Ca2+-dependent lysosomal exocytosis without broadly suppressing membrane trafficking. This guide connects practical cell-based assays with disease-model questions involving membrane repair, protease release, and growth factor signaling.
Fluorouracil: A Biomarker-Aware Research Guide
2026-09-07
Explore how Fluorouracil and 5-Fluorouracil connect thymidylate synthase inhibition with biomarker-aware cancer assays. This guide integrates product benchmarks with SMC2/SMC4 findings to improve experimental design across colon and breast cancer research.
Diminazene Aceturate: Mechanism and Research Use
2026-09-07
Diminazene Aceturate is a water- and DMSO-soluble diamidine used in trypanosome parasite research. A February 2024 mouse study used it as a pharmacological ACE2 activator and linked treatment to MasR–Sirt1-mediated mitochondrial biogenesis, but the result remains preclinical and does not establish a clinical indication.
Propidium Iodide: Assay Decisions Beyond Cell Death
2026-09-05
Propidium iodide is more than a red-fluorescent DNA intercalating dye: its signal must be matched to membrane status, DNA content, and sample handling. This guide connects rigorous PI assay design with lessons from rapid microwave processing of lactoferrin.
DPPH Radical: Mechanism and Antioxidant Screening
2026-09-04
DPPH (2,2-Diphenyl-1-Picrylhydrazyl) is a nitrogen-centered stable radical used for rapid, colorimetric in vitro antioxidant screening. Its violet-to-yellow reduction signal supports comparative radical-scavenging measurements, but results require matrix controls and orthogonal biochemical assays.
Mitoxantrone: Reading ABCG2 Resistance Correctly
2026-09-04
Mitoxantrone is more than a topoisomerase II inhibitor: its intracellular exposure can be reshaped by ABCG2-mediated efflux. This article presents a mechanistic framework for separating transporter effects from downstream drug resistance and designing more informative assays.
Thapsigargin for Calcium Signaling Workflows
2026-09-03
Thapsigargin provides a fast, tunable way to connect SERCA inhibition with cytosolic calcium elevation, ER stress, and programmed cell death. This workflow guide shows how to use it as a quantitative control in calcium signaling, apoptosis, viral necroptosis, and disease-model experiments while avoiding common interpretation errors.
0.4% Trypan Blue Solution: Practical Cell Viability Guide
2026-09-03
0.4% Trypan Blue Solution provides a membrane-exclusion method for cell viability measurement, cell counting, and rapid live/dead cell discrimination. It is intended for controlled biological research workflows, not for diagnostic, clinical, or medical use, and it should not be treated as a pathway-specific apoptosis assay.
Palonosetron Hydrochloride: 5-HT3 Evidence
2026-09-02
Palonosetron hydrochloride is a highly selective 5-HT3 receptor antagonist with strong activity at 5-HT3A and 5-HT3AB receptors. Its long half-life supports chemotherapy-induced nausea and vomiting prevention, while transporter assays provide a separate research application for OCT2 and MATE1 renal transporter inhibition.
JXE-23 in HCC: Autophagy, Arrest, and Signaling
2026-09-02
A 2024 study identified the fern-derived diterpene JXE-23 as a selective inhibitor of HepG2 hepatocellular carcinoma cell growth, combining G2/M arrest with migration suppression and induction of protective autophagy. Its connection to the CIP2A/p-AKT/c-Myc axis suggests a mechanistic framework for testing JXE-23 and autophagy modulation in anticancer drug research.
PD 0332991 (Palbociclib) HCl: Lab Guide
2026-09-01
This scenario-based guide explains how PD 0332991 (Palbociclib) HCl, SKU A8316, can support interpretable cell-cycle, viability, and proliferation experiments. It connects CDK4/6 mechanism, Rb-status selection, formulation, assay controls, and practical vendor evaluation to evidence from product data and published genomics research.
PGF2α/PTGFR in Endometrial Breakdown and Vascular Dynamics
2026-09-01
A 2024 Reproductive Sciences study identifies PGF2α signaling through PTGFR as a regulator of endometrial breakdown and vascular permeability in a mouse menstrual-like model. By combining pharmacological inhibition, molecular profiling, histology, and HIF-1α promoter-occupancy analysis, the study proposes a mechanistic HIF-1α–PTGFR axis with relevance to menstrual and reproductive vascular biology.
614 records 9/41 page Previous Next First page 上5页 678910 下5页 Last page